Back
Puma Biotechnology 10K Form
Sell
47
PBYI
Puma Biotechnology
Last Price:
2.91
Seasonality Move:
27.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PBYI News And Ratings
See the #1 stock for the next 7 days that we like better than PBYI
PBYI Financial Statistics
Sales & Book Value
| Annual Sales: | $235.64M |
|---|---|
| Cash Flow: | $11.02M |
| Price / Cash Flow: | 3.94 |
| Annual Sales: | $1.45 |
| Price / Book: | 1.89 |
Profitability
| EPS (TTM): | 0.47000 |
|---|---|
| Net Income (TTM): | $23.24M |
| Gross Margin: | $172.96M |
| Return on Equity: | 44.22% |
| Return on Assets: | 10.82% |
Puma Biotechnology Earnings Forecast
Key Puma Biotechnology Financial Ratios
- The Gross Profit Margin over the past 16 years for PBYI is 73.40%.
- The Selling, General & Administrative Expenses for PBYI have been equal to 37.53% of Gross Profit Margin.
- The Research & Development expenses have been 21.38% of Revenue.
- The Interest Expense is 61.74% of Operating Income.
- The Net Earning history of PBYI is 9.16% of Total Revenues.
- Per Share Earnings over the last 16 years have been positive in 9 years.
Puma Biotechnology Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PBYI |
| CUSIP: | 74587V |
| Website: | pumabiotechnology.com |
Debt
| Debt-to-Equity Ratio: | 1.1 |
|---|---|
| Current Ratio: | 1.42 |
| Quick Ratio: | 1.37 |
Price-to-Earnings
| Trailing P/E Ratio: | 6.09 |
|---|---|
| Forward P/E Ratio: | 4.61 |
PBYI Technical Analysis vs Fundamental Analysis
Sell
47
Puma Biotechnology (PBYI)
is a Sell
Is Puma Biotechnology a Buy or a Sell?
-
Puma Biotechnology stock is rated a Sell
The current Puma Biotechnology [PBYI] share price is $2.84. The Score for PBYI is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.